Intensive Versus Conventional Digoxin Use in Patients With Heart Failure

NCT02797145 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Heart Failure

Interventions

DRUG: Digoxin dose-adjusted
DRUG: Standard dose

Sponsor

Hospital Ana Nery